In Brief:
Micrometastases, defined as microscopic cancer cells spatially separated from the gross tumor, are associated with worse overall and recurrence-free survival after resection of colorectal liver metastases. Risk factors for the presence of micrometastases are RAS/TP53 co-mutation and nonreceipt of preoperative therapy with bevacizumab.
